The store will not work correctly when cookies are disabled.
2-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)amino)-3-hydroxynaphthalene-1,4-dione
ID: ALA4546952
PubChem CID: 155552167
Max Phase: Preclinical
Molecular Formula: C18H13NO5
Molecular Weight: 323.30
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C(O)=C(Nc2ccc3c(c2)OCCO3)C(=O)c2ccccc21
Standard InChI: InChI=1S/C18H13NO5/c20-16-11-3-1-2-4-12(11)17(21)18(22)15(16)19-10-5-6-13-14(9-10)24-8-7-23-13/h1-6,9,19,22H,7-8H2
Standard InChI Key: KKCMDEWZFISKHC-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
34.1061 -10.5369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1050 -11.3645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8200 -11.7776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8182 -10.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5338 -10.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5327 -11.3620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2459 -11.7751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9647 -11.3640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9659 -10.5353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2482 -10.1176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2482 -9.2923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.2435 -12.6004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6816 -10.1244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6783 -11.7787 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3942 -11.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1049 -11.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1045 -10.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3920 -10.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8230 -10.5503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8176 -11.3745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5247 -11.7891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.2419 -11.3840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2474 -10.5597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5356 -10.1406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
7 12 2 0
9 13 1 0
8 14 1 0
14 15 1 0
15 16 2 0
16 20 1 0
19 17 1 0
17 18 2 0
18 15 1 0
19 20 2 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.30 | Molecular Weight (Monoisotopic): 323.0794 | AlogP: 2.72 | #Rotatable Bonds: 2 |
Polar Surface Area: 84.86 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.37 | CX Basic pKa: ┄ | CX LogP: 1.40 | CX LogD: 0.33 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.88 | Np Likeness Score: -0.36 |
References
1. Calil FA, David JS, Chiappetta ERC, Fumagalli F, Mello RB, Leite FHA, Castilho MS, Emery FS, Nonato MC.. (2019) Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase., 167 [PMID:30776695] [10.1016/j.ejmech.2019.02.018] |